we are playing a game of homerun derby it's all or nothing...if things work out in our favor and we get good news on the 18th we will have a nice run up...BUT if we were to get full FDA green light with only 53.5mil o/s that's a lottery ticket right there. the market caps for companies with fda approved cancer drugs tend to be in the billions...leaving us in the $20/sh + range.
dendreon has a mkt cap of 5.91B...different drug all together i understand that....i'm just saying a $1 share price is not what will be looking at here.